Skip to main content
IPAR logo

IPAR · Interparfums Inc

Track IPAR — free
Market Cap
$3.59B
Shares
32.03M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$112.05 Open$112.77 Day$111.39–113.36 52W close$79.57–128.55 Avg vol 30d233K Short int1.9M · 6.1% float · 8.8d Short vol62% Last earningsAug 4, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 4

Up next

Next earnings call
Nov 2, 2026 Est · unconfirmed · in 7 wks
filed Aug 4, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.50B
Trailing 12 months
Net income (TTM)
$167.76M
Trailing 12 months
Revenue growth YoY
+2.1%
Year over year
Operating margin
17.3%
Trailing 12 months
P / E (TTM)
21.4
Trailing earnings · reciprocal yield 4.7%
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
$12.76M
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
-0.4%
Year over year · fewer shares
Price change (1Y)
+5.0%
Trailing year
Short interest
6.1%
Latest settlement · 8.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Sell Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 17.1 · elevated Equity put/call 0.67
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg +13%
above
Price vs 50-day avg −6%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 66%
mid-range
Momentum
relative strength
Strong
1-month return −2%
trailing
6-month return +24%
trailing
YTD return +32%
this year
Relative strength +7%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $119 › 200d $99 — 50d above 200d
Institutional flow Accumulating
+4% holders QoQ · +48 funds added
Insider flow Distributing
Net -$105.2K over 90 days · 100% sells
Short interest Rising
6.08% of float · ▲ +4.2% MoM · 8.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
316 holders — near 3-yr high, broad support
Squeeze score 67
elevated · 0–100
Fundamentals
Excellent
Revenue growth +21%
Y/Y
Gross margin 72%
contracting
EPS growth +2%
Y/Y
Free cash flow $190.5M
Valuation P/E 21.4
below peers
Quant / Vol
risk profile
Moderate
Volatility 30%
annualized · 1-yr
Max drawdown −25%
past year
ATR 3.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 1 of last 2
Latest guidance · from the 8-K filed Aug 4, 2026
Sales · 2026 $1.48B
prior FY $1.49B midpoint −0.6% Y/Y
EPS · 2026 $4.85
prior FY $5.24 midpoint −7.4% Y/Y
Prior guidance period ended · from the 8-K filed Aug 6, 2024
Net sales · full year 2024 $1.45B
Earnings per diluted share · full year 2024 $5.15
Guided vs delivered · last 2 settled
Net sales full year 2024
guided $1.45B
$1.45B Beat +0.2%
Earnings per diluted share full year 2024
guided $5.15
$5.12 Miss −0.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+13% Bullish
Price vs 50-day avg
−6% Bearish
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
66% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $119 › 200d $99 — 50d above 200d
Institutional flow Accumulating
+4% holders QoQ · +48 funds added
Insider flow Distributing
Net -$105.2K over 90 days · 100% sells
Short interest Rising
6.08% of float · ▲ +4.2% MoM · 8.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
316 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $80 Now $112 · 66% Range high $129
vs 200-day avg +13% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Household & Personal Products — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IPAR
Interparfums Inc
this stock
$3.59B +32.1% +21.3% 21.4 6.1%
PG
PROCTER & GAMBLE Co
$335.19B +2.0% +3.3% 21.8 1.2%
UL
Unilever PLC
$134.65B -2.8% 0.2%
CL
Colgate Palmolive Co
$70.45B +11.2% +1.7% 34.9 2.2%
RBGLY
Reckitt Benckiser Group PLC
$43.59B 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
316
% held
67.2%
Net QoQ
+1.8M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
323
View
Short & Settlement
Short Interest Rising
Shares short
1.9M
Days to cover
8.8d
Change
+79.4K sh
View
Short Volume
Short vol %
62%
As of
Sep 15, 2026
Short Total
View
Fails to Deliver
FTD shares
7
Value
$817
As of
Aug 27, 2026
View
Off-Exchange
Off-exchange %
36.6%
Week of
Aug 10, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$105.2K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.3B
Net income (FY)
$168.4M
EPS diluted
$5.24
View
Buybacks
Authorized
shares 260.0K
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 4, 2026
This year
14
View
Proposed Sales
Value
$105.2K
Shares
900
Filed
Aug 27, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 4, 2026
View

Performance

5D 20D 120D MTD YTD
IPAR -4.0% -2.3% +23.6% -4.6% +32.1%
SPY -1.2% -2.0% +16.1% -0.8% +11.6%
vs SPY -2.8% -0.3% +7.5% -3.8% +20.5%

Capital returns

Buyback program · as of Apr 30, 2025
Authorized
shares 260,000
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 822663 CUSIP 458334109 13F (30d) 17 filings 16 filers Visit website Investor relations